Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0 % diclofenac sodium topical gel (Solaraze). - Nelson,C.; Rigel,D.; Smith,S.; Swanson,N.; Wolf,J. (J Drugs Dermatol, 2004)